A Novel Approach Targets Relapsed Acute Myeloid Leukemia with Precision: HLA-DRB1 Identified as a Promising Antigen for CAR Therapy
The persistent challenge in developing effective anti-cancer therapies lies in the ability to selectively eliminate...
